Cooperative Weichteilsarkom Study Group Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2005
NCT00130858
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Cooperative Weichteilsarkom Studie | Cooperative Weichteilsarkom Study Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Histiocytoma (Phase 3)

Histiocytoma, Benign Fibrous (Phase 3)

Histiocytoma, Malignant Fibrous (Phase 3)

Rhabdomyosarcoma (Phase 3)

Sarcoma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7